Institutional investors hold a majority ownership of PFE through the 73.86% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry.
| Mutual fund holders | 37.64% |
| Other institutional | 36.23% |
| Individual stakeholders | 0.20% |